603811.SS Stock Analysis
60
Neutral
Based on Eyestock quantitative analysis, 603811.SS`s fundamental data and valuation indicate an investment grade of Neutral at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly undervalued
Market cap $B
0.309
Dividend yield
2.90 %
Shares outstanding
233.79 B
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical drugs and preparations of raw materials. The company is headquartered in Shanghai, Shanghai and currently employs 719 full-time employees. The company went IPO on 2017-03-15. The Company’s products are on the spectrum from arthritis, dieresis to anti-virus and anti-tumor. The main products include bulk pharmaceutical chemicals, injections, capsules, intermediates and others.